Risk Factors | Low BMD | Normal BMD | Control Group | p |
---|---|---|---|---|
Gender: Male: N (%) Female: N (%) |
13 (32. 5) 15 (37. 5) |
4 (10) 8 (20) |
15(47) 17(53) |
NS § |
Age (years)* | 46.42 ± 14.33 | 39.75 ± 10.42 | 44,72 ± 14,12 | NS ¶ |
BMI (kg/m2)* | 20.71 ± 3.06 | 21.52 ± 4.59 | 25.05± 3,96 | 0.001 ¶ |
Type of IBD: CD: N (%) UC: N (%) |
14 (35) 14 (35) |
5 (12.5) 7 (17.5) |
NS § | |
IBD duration (months)* | 58.41 ± 86.23 | 45.92 ± 54.75 | NS ¥ | |
Corticosteroids: Yes: N (%) No: N (%) |
16 (40) 12 (30) |
6 (15) 6 (15) |
0 0 |
NS § |
Cumulative dose of steroids (mg)** | 515 (0 – 11200) | 250 (0– 23900) | 0 | NS ¥ |
Bowel surgery: Yes: N (%) No: N (%) |
2 (5) 24 (60) |
4 (10) 10 (25) |
0 0 |
NS § |
Disease localization (CD): Colonic: N (%) Ileocolonic + ileal: N (%) |
2 (10.5) 12 (63.2) |
0 5 (26.3) |
NS § | |
Disease localization (UC): Proctitis: N (%) Left side colitis+pancolitis: N (%) |
3 (14.3) 11 (52.4) |
2 (9.5) 5 (23.8) |
NS § | |
ESR* | 49 ± 15.67 | 31.8 ± 13.1 | 10 | 0.039 ¶ |
Calcium (mmol/l)* | 2.43 ±0.11 | 2.42 ±0.16 | 2,42 ± 0,10 | NS ¶ |
Phosphorus (mmol/l)* | 1.22 ±0.19 | 1.23 ±0.25 | 1,13 ± 0,20 | NS ¶ |
Alcaline phosphatase (UI/L)* | 108.12 ±45.26 | 89.8 ±41 | 88,75 ± 44,18 | NS ¶ |
25-OH vitamin D (ng/ml)** | 3,65 | 3 | 9.03 | 0.009 ¥ |
PTH (pg/ml) ** | 42.11 | 55.4 | 41.57 | NS ¥ |
Serum osteocalcin (ng/ml) ** | 28.74 | 18.51 | 24.6 | NS ¥ |
Urinairy CTX (µg/ mmol urinary creatinine)** | 541.58 | 358.15 | 343.3 | NS ¥ |
Fractures (%) | 0 | 0 | 0 | NS § |